Psychostimulants may threaten male fertility—and cannabis can add risk
Impact of Psychostimulant Exposure on Male Fertility and Spermatogenic Function.
AI Summary
This narrative review examines how psychostimulants—including cocaine, methamphetamine, methylphenidate, nicotine, and caffeine—may affect male reproductive health. Across animal studies, human observations, imaging, and mechanistic research, these substances are associated with disruption of the hypothalamic-pituitary-gonadal axis, lower testosterone, and impaired activity in testicular cells involved in sperm production. The abstract does not report quantitative results such as sample sizes, percentages, or effect sizes.
Reported effects include poorer sperm concentration and motility, abnormal morphology, greater DNA fragmentation, mitochondrial problems, and oxidative stress. The review also notes that co-exposure with alcohol, cannabis, or antidepressants may add to reproductive toxicity, while adolescent exposure and persistent epigenetic changes could have longer-term consequences. For cannabis users, the key takeaway is that cannabis may be an important additional factor when combined with psychostimulants, but this review does not establish cannabis-specific fertility effects or determine whether the reported harms are reversible. The authors call for counseling, hormone and semen monitoring, prevention, and further research into dose thresholds and long-term reproductive outcomes.
💡 Key Findings
📄
Original Abstract
Related Research
Similar Studies
More Addiction research papers you might find interesting.
EEG profiles recurred across groups, but individual reliability was low
A proposed risk-factor approach links cannabis use and other exposures to…
Umbrella review links frequent cannabis use with psychosis risk
Explore More Research
Stay informed about the latest cannabis science.